GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $151,480 | -54.7% | 126,233 | -52.5% | 0.00% | -50.0% |
Q1 2023 | $334,711 | -77.0% | 265,644 | +118.6% | 0.00% | -80.0% |
Q3 2022 | $1,456,000 | +203.3% | 121,546 | +111.9% | 0.01% | +233.3% |
Q2 2022 | $480,000 | +22.1% | 57,367 | +26.8% | 0.00% | +50.0% |
Q1 2022 | $393,000 | -24.0% | 45,254 | -1.0% | 0.00% | -33.3% |
Q4 2021 | $517,000 | -11.6% | 45,719 | -1.7% | 0.00% | 0.0% |
Q3 2021 | $585,000 | – | 46,506 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |